4/A

PRIMARY DOCUMENT

Company: PLUS THERAPEUTICS, INC.
Filed: February 22, 2006
Period of Report: February 14, 2006
Accession Number: 0001168215-06-000010

View Document ↗ View on SEC.gov ↗